Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
38.81
+0.95 (2.51%)
Nov 22, 2024, 4:00 PM EST - Market closed
Verona Pharma Employees
Verona Pharma had 79 employees as of December 31, 2023. The number of employees increased by 43 or 119.44% compared to the previous year.
Employees
79
Change (1Y)
43
Growth (1Y)
119.44%
Revenue / Employee
$71,190
Profits / Employee
-$1,945,861
Market Cap
3.18B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
Acadia Healthcare Company | 23,500 |
Envista Holdings | 12,800 |
Neogen | 2,917 |
PTC Therapeutics | 1,055 |
Veracyte | 815 |
Denali Therapeutics | 445 |
Agios Pharmaceuticals | 386 |
VRNA News
- 4 days ago - Verona Pharma Announces December 2024 Investor Conference Participation - GlobeNewsWire
- 13 days ago - Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value - CNBC
- 18 days ago - Verona Pharma to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 18 days ago - Verona Pharma plc (VRNA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewsWire
- 6 weeks ago - Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board - Business Wire
- 7 weeks ago - Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024 - GlobeNewsWire